Halda Therapeutics

News

Johnson & Johnson has added to the flurry of M&A deals in pharma with an agreement to buy Halda Therapeutics and its RIPTAC anticancer platform.

News

Just weeks after forming as a spinout from Endevica Bio, obesity drug developer Kalohexis has filed for an IPO.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.